Glenmark gets FDA OK for generic Zytiga

Press enter to search
Close search
Open Menu

Glenmark gets FDA OK for generic Zytiga

By Sandra Levy - 10/17/2019

Glenmark has received the Food and Drug Administration’s blessing for abiraterone acetate tablets in a dosage strength of 250 mg.

The product is a generic version of Janssen Biotech’s Zytiga tablets, 250 mg.         

Zytiga tablets, 250 mg had a market value of $794.1 million for the 12 month period ended August 2019, according to IQVIA.

 

RELATED TOPICS